INR 20.96
(-4.86%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 5016.00 INR | 110.05% |
2022 | 2388.00 INR | -46.95% |
2021 | 4501.00 INR | 38.51% |
2020 | 3249.50 INR | 19.79% |
2019 | 2712.60 INR | 99.24% |
2018 | 1361.45 INR | 1272.37% |
2017 | -116.13 INR | 88.01% |
2016 | -968.72 INR | -749.47% |
2015 | -114.04 INR | 29.55% |
2014 | -161.87 INR | -358.88% |
2013 | -35.28 INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 43.10 INR | -99.14% |
2023 Q4 | 5015.50 INR | 0.0% |
2023 FY | 5015.50 INR | 110.03% |
2023 Q1 | 47.00 INR | -98.03% |
2022 Q1 | 73.00 INR | -98.38% |
2022 Q3 | 56.00 INR | -98.91% |
2022 Q4 | 2388.00 INR | 4164.29% |
2022 Q2 | 5155.00 INR | 6961.64% |
2021 Q2 | 3887.00 INR | 4419.77% |
2021 Q4 | 4501.00 INR | 1714.92% |
2021 Q3 | 248.00 INR | -93.62% |
2021 Q1 | 86.00 INR | -97.35% |
2020 Q1 | 123.00 INR | -95.47% |
2020 Q4 | 3249.50 INR | 1869.39% |
2020 Q2 | 3170.00 INR | 2477.24% |
2020 Q3 | 165.00 INR | -94.79% |
2019 Q3 | 78.00 INR | -95.94% |
2019 Q4 | 2712.60 INR | 3377.69% |
2019 Q2 | 1922.00 INR | 1282.73% |
2019 Q1 | 139.00 INR | -89.79% |
2018 Q3 | 134.00 INR | 200.0% |
2018 Q4 | 1361.45 INR | 916.01% |
2018 Q2 | -134.00 INR | -215.52% |
2018 Q1 | 116.00 INR | 199.89% |
2017 Q3 | 66.00 INR | 200.0% |
2017 Q2 | -66.00 INR | -106.81% |
2017 Q1 | 968.72 INR | 200.0% |
2017 Q4 | -116.13 INR | -275.95% |
2016 Q2 | 145.00 INR | 27.19% |
2016 Q3 | 55.00 INR | -62.07% |
2016 Q4 | -968.72 INR | -1861.31% |
2016 Q1 | 114.00 INR | 199.97% |
2015 Q4 | -114.04 INR | -165.92% |
2015 Q1 | 162.00 INR | 200.08% |
2015 Q2 | 127.00 INR | -21.6% |
2015 Q3 | 173.00 INR | 36.22% |
2014 Q3 | 169.00 INR | 200.0% |
2014 Q4 | -161.87 INR | -195.78% |
2014 Q1 | 35.00 INR | 199.22% |
2014 Q2 | -169.00 INR | -582.86% |
2013 Q2 | 56.00 INR | 0.0% |
2013 Q3 | 44.00 INR | -21.43% |
2013 Q4 | -35.28 INR | -180.17% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.35 Billion INR | 100.0% |
Biocon Limited | 140.18 Billion INR | 100.0% |
Blue Jet Healthcare Limited | -830.93 Million INR | 100.001% |
Concord Biotech Limited | -372.86 Million INR | 100.001% |
Dishman Carbogen Amcis Limited | 18.99 Billion INR | 100.0% |
FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 100.0% |
GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | 108.259% |
Lyka Labs Limited | 527.01 Million INR | 99.999% |
Panacea Biotec Limited | -1.18 Billion INR | 100.0% |
SAMSRITA LABS LIMITED | 21.98 Million INR | 99.977% |
SMS Lifesciences India Limited | 992.31 Million INR | 99.999% |
Supriya Lifescience Limited | -694.68 Million INR | 100.001% |
Syngene International Limited | -83 Million INR | 100.006% |
TAKE Solutions Limited | 361.37 Million INR | 99.999% |
Titan Biotech Limited | 54.62 Million INR | 99.991% |
Transgene Biotek Limited | 139.93 Million INR | 99.996% |
Vanta Bioscience Limited | 607.93 Million INR | 99.999% |